Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2012-10-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
OPERA Database - Crohn's Protocol
NCT01720368
Renal and Urinary Manifestations of Chronic Inflammatory Bowel Diseases.
NCT06814392
Development of a Questionnaire Based on Patients' Messages on an Internet Forum for Flare Detection in IBD
NCT04180345
Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease
NCT03239704
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
NCT02438410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1
First 50 patients
No interventions assigned to this group
Cohort 2
2nd group of 50 patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* current of past prescription for anti-TNF medication
* at least 18 years of age
* access to medical records to verify information
* 20% of participants will be patients diagnosed within 1 year of inclusion
Exclusion Criteria
* unable to access or use internet
* less than 18 years of age
* diagnosis of crohn's disease or IBD-U
* illiterate or does not possess minimum level of literacy required to complete questionnaire
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Janssen Services, LLC
INDUSTRY
Dartmouth-Hitchcock Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REMICADEIBD4007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.